SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
المؤلف الرئيسي: | Meem, Manila |
---|---|
مؤلفون آخرون: | Akter, Dr. Raushanara |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
Brac University
2023
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://hdl.handle.net/10361/18081 |
مواد مشابهة
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
بواسطة: Islam, Saidul
منشور في: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
بواسطة: Jahan, Nusrat
منشور في: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
بواسطة: Flora, Sanzida Alam
منشور في: (2024) -
Immunotherapy in the Management of Lung Cancer
بواسطة: Tasnim, Humayra
منشور في: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
بواسطة: Ratu, Tabassum
منشور في: (2024)